euragen® for the relief of neuropathic pain: a randomised, double-blind, placebo controlled clinical trial

Completed

• Conditions: Peripheral neuropathy; Nervous System Diseases; Other polyneuropathies

• Registration Number: ISRCTN13226601
• Lead Sponsor: Origin BioMed, Inc. (Canada)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-06-13
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Male and female, over 21 years
2. Diagnosed neuropathic pain for more three months
3. Pain level between 3 - 8 on a 0 - 10 visual pain scale
4. Does not have mental and communication impairments

Exclusion Criteria

1. Pregnant
2. Have other types of pain
3. Skin condition
4. Central nerve impairment

Study & Design

• Study Type: Interventional
• Study Design: Not specified